Dawson’s Creek star James Van Der Beek has said he has been diagnosed with bowel cancer.
The 47-year-old American actor – famous for his role as Dawson Leery in the drama series – told US outlet People on Sunday that he has colorectal cancer.
Bowel cancer – sometimes also called colorectal cancer – starts in the colon or the rectum, which makes up the large intestine in the digestive system.
It is one of the most common types of cancer in the UK, according to Cancer Research UK, with around 42,900 people diagnosed each year.
Speaking to People, Van Der Beek added: “I’ve been privately dealing with this diagnosis and have been taking steps to resolve it, with the support of my incredible family.
“There’s reason for optimism, and I’m feeling good.”
The 47-year-old actor is best known for playing Dawson Leery in Dawson’s Creek. Pic: Columbia Tristar/Everett/Shutterstock
He said he has been prioritising time with his wife Kimberly Van Der Beek and their six children, Olivia, Joshua, Annabel, Emilia, Gwendolyn and Jeremiah.
The actor – also known for his roles in Don’t Trust The B—- In Apartment 23, CSI: Cyber, and the FX drama Pose – also posted on Instagram about his diagnosis.
Read more:
Music titan Quincy Jones dies
Dawson’s Creek star Obi Ndefo dies aged 51
Foodie describes life without tongue after mouth cancer
Van Der Beek said he planned on “planned on talking about it at length with People magazine at some point soon,” but instead announced the news on Sunday morning “when I was informed that a tabloid was going to run with the news”.
He then added: “I’ve been dealing with this privately until now, getting treatment and dialling in my overall health with greater focus than ever before.
“I’m in a good place and feeling strong. It’s been quite the initiation, and I’ll tell you more when I’m ready.”
Keep up with all the latest news from the UK and around the world by following Sky News
Tap here
In December, Van Der Beek will appear in the Fox special The Real Full Monty, which will see male celebrities strip naked to raise awareness for prostate, testicular, and colorectal cancer testing and research.
